Pharmacology & ToxicologyCell SystemsPeer-reviewed
Adaptation of human iPSC-derived cardiomyocytes to tyrosine kinase inhibitors reduces acute cardiotoxicity via metabolic reprogramming
DOI 10.1016/j.cels.2019.03.009
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
3 papers
Recent·Most cited
M. Hafner, C. E. Mills, K. Subramanian…·P. Sorger
This study compares the mechanisms of three FDA-approved CDK4/6 inhibitors and finds significant differences in their transcriptional, proteomic, and cellular effects, suggesting potential for differential clinical use.
J. Y. Hwang, N. Mannowetz, Y. Zhang…·J.-J. Chung
This study identifies EFCAB9 as a pH-dependent Ca2+ sensor that modulates CatSper channel activity and sperm motility through its interaction with CATSPERζ.